Yellow 560 Microscope for Intraoperative Visualization of Fluorescein Stained Intracranial Lesions

PHASE4UnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

April 30, 2019

Conditions
Cerebrovascular DisordersIntracranial Neoplasms
Interventions
DRUG

Fluorescein Sodium

Conventional microsurgical and biopsy procedures and techniques including histopathology and intraoperative imaging will be performed through the completion of the surgery. The surgeon will resect and remove what he believes is the tumor based on previously known criteria (standards of care) regardless of what the Fluorescein angiography demonstrates. For vascular lesions, fluorescein sodium 10% (100mg/1mL) will be injected and used to assess its application after the conventional methods have confirmed the exclusion of the aneurysm. No patient's care will be affected by the results of the Fluorescein angiography.

Trial Locations (1)

32804

RECRUITING

Florida Hospital, Orlando

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AdventHealth

OTHER